Johnson & Johnson Breaking Out Diagnostics From Pharmaceuticals Group
This article was originally published in The Gray Sheet
Executive SummaryJohnson & Johnson has decided to create a fourth operating unit by separating the diagnostics business from the Pharmaceuticals Group and placing it under the leadership of Ronald Gelbman, the firm announced June 8.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.